| HMDB0004684 | 11,12,15-THETA | |  | C20H34O5 | 354.481 354.240624198 | Not Available |
| HMDB0004673 | 11,12-Epoxyeicosatrienoic acid | 123931-40-8 |  | C20H32O3 | 320.473 320.23514489 | Not Available |
| HMDB0004694 | 11,14,15-THETA | |  | C20H34O5 | 354.481 354.240624198 | Not Available |
| HMDB0004693 | 11H-14,15-EETA | 219535-29-2 |  | C20H32O4 | 336.4657 336.230059512 | Not Available |
| HMDB0004702 | 12,13-EpOME | |  | C18H32O3 | 296.4449 296.23514489 | Not Available |
| HMDB0013911 | 12-Hydroxynevirapine | |  | C15H14N4O2 | 282.2973 282.111675712 | - Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. [PubMed:19515014 ]
|
| HMDB0004264 | 14,15-Epoxy-5,8,11-eicosatrienoic acid | 81276-03-1 |  | C20H32O3 | 320.4663 320.23514489 | Not Available |
| HMDB0004244 | 15(S)-HPETE | 70981-96-3 |  | C20H32O4 | 336.4657 336.230059512 | Not Available |
| HMDB0005050 | 15H-11,12-EETA | 877878-78-9 |  | C20H32O4 | 336.4657 336.230059512 | Not Available |
| HMDB0004680 | 16(R)-HETE | |  | C20H32O3 | 320.4663 320.23514489 | Not Available |
| HMDB0011136 | 19(S)-HETE | 79551-85-2 |  | C20H32O3 | 320.4663 320.23514489 | Not Available |
| HMDB0003955 | 19-Hydroxyandrost-4-ene-3,17-dione | 510-64-5 |  | C19H26O3 | 302.4079 302.188194698 | Not Available |
| HMDB0006769 | 19-Hydroxytestosterone | 2126-37-6 |  | C19H28O3 | 304.4238 304.203844762 | Not Available |
| HMDB0006768 | 19-Oxoandrost-4-ene-3,17-dione | |  | C19H24O3 | 300.3921 300.172544634 | Not Available |
| HMDB0003959 | 19-Oxotestosterone | 4075-13-2 |  | C19H26O3 | 302.4079 302.188194698 | Not Available |
| HMDB0013858 | 3-Dechloroethylifosfamide | 36761-83-8 |  | C5H12ClN2O2P | 198.588 198.032491857 | - Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
- Lokiec F: Ifosfamide: pharmacokinetic properties for central nervous system metastasis prevention. Ann Oncol. 2006 May;17 Suppl 4:iv33-6. [PubMed:16702183 ]
- Roy P, Yu LJ, Crespi CL, Waxman DJ: Development of a substrate-activity based approach to identify the major human liver P-450 catalysts of cyclophosphamide and ifosfamide activation based on cDNA-expressed activities and liver microsomal P-450 profiles. Drug Metab Dispos. 1999 Jun;27(6):655-66. [PubMed:10348794 ]
|
| HMDB0013840 | 3-Hydroxymethylantipyrine | 18125-49-0 |  | C11H12N2O2 | 204.2252 204.089877638 | - Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
|
| HMDB0013897 | 4-ene-Valproic acid | |  | C8H14O2 | 142.1956 142.099379692 | - Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
- Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. [PubMed:19515014 ]
|
| HMDB0013856 | 4-Hydroxycyclophosphamide | 40277-05-2 |  | C7H15Cl2N2O3P | 277.085 276.019734282 | - Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
|
| HMDB0014018 | 4-Hydroxypropofol | |  | C12H18O2 | 194.2701 194.13067982 | - Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
|
| HMDB0002190 | 5,6-Epoxy-8,11,14-eicosatrienoic acid | 81246-84-6 |  | C20H32O3 | 320.4663 320.23514489 | Not Available |
| HMDB0004081 | 6-Hydroxymelatonin | 2208-41-5 |  | C13H16N2O3 | 248.2777 248.116092388 | Not Available |
| HMDB0003956 | 7a-Hydroxytestosterone | 2141-17-5 |  | C19H28O3 | 304.4238 304.203844762 | Not Available |
| HMDB0002232 | 8,9-Epoxyeicosatrienoic acid | 81246-85-7 |  | C20H32O3 | 320.4663 320.23514489 | Not Available |
| HMDB0004701 | 9,10-Epoxyoctadecenoic acid | |  | C18H32O3 | 296.4449 296.23514489 | Not Available |